RLAYNasdaq United States
Market cap
$3.788 B
$19.77 +0.10%
Close of 7 Aug 2026
Revenue
$15.4M
#3082 by revenue
Earnings
-$276.5M
Loss-making
Shares outstanding
219,141,631
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Relay Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.